These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9029109)

  • 21. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
    López D; Del Val M
    J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Context-dependent immunogenicity of an S206G-substituted H-2Db-restricted simian virus 40 large T antigen epitope I variant.
    Mylin LM
    J Immunol; 1999 Feb; 162(4):2171-9. PubMed ID: 9973492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins.
    Weber F; Kochs G; Gruber S; Haller O
    Virology; 1998 Oct; 250(1):9-18. PubMed ID: 9770415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo.
    Lipatov AS; Yen HL; Salomon R; Ozaki H; Hoffmann E; Webster RG
    Arch Virol; 2008; 153(3):427-34. PubMed ID: 18058063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of peptide binding to purified antibody-bound H-2Db and H-2Db beta 2m complexes.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3082-93. PubMed ID: 7690793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
    Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
    J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H2-M3 presents a nonformylated viral epitope to CTLs generated in vitro.
    Byers DE; Fischer Lindahl K
    J Immunol; 1998 Jul; 161(1):90-6. PubMed ID: 9647211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
    Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
    J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations.
    Rimmelzwaan GF; Berkhoff EG; Nieuwkoop NJ; Fouchier RA; Osterhaus AD
    J Virol; 2004 Aug; 78(16):8946-9. PubMed ID: 15280506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
    Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y
    J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential processing of influenza nucleoprotein in human and mouse cells.
    Braud VM; McMichael AJ; Cerundolo V
    Eur J Immunol; 1998 Feb; 28(2):625-35. PubMed ID: 9521073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
    Blake NW; Kettle S; Law KM; Gould K; Bastin J; Townsend AR; Smith GL
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2393-8. PubMed ID: 7561783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High peptide affinity for MHC class I does not correlate with immunodominance.
    Müllbacher A; Lobigs M; Yewdell JW; Bennink JR; Tha Hla R; Blanden RV
    Scand J Immunol; 1999 Oct; 50(4):420-6. PubMed ID: 10520183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames.
    Bullock TN; Eisenlohr LC
    J Exp Med; 1996 Oct; 184(4):1319-29. PubMed ID: 8879204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes.
    Eisenlohr LC; Yewdell JW; Bennink JR
    J Exp Med; 1992 Feb; 175(2):481-7. PubMed ID: 1732413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2002 Mar; 76(5):2567-72. PubMed ID: 11836437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visualization of microtubule-mediated transport of influenza viral progeny ribonucleoprotein.
    Momose F; Kikuchi Y; Komase K; Morikawa Y
    Microbes Infect; 2007 Oct; 9(12-13):1422-33. PubMed ID: 17905627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.